Screening Adults for Type 2 Diabetes: A Review of the Evidence for the U.S. Preventive Services Task Force

  1. Susan L. Norris, MD, MPH;
  2. Devan Kansagara, MD;
  3. Christina Bougatsos, BS; and
  4. Rongwei Fu, PhD
  1. From the Oregon Evidence-based Practice Center of the Oregon Health & Science University and Portland Veterans Administration Medical Center, Portland, Oregon.
    1. Appendix Figure 1.
      View larger version:
      Appendix Figure 1. Analytic framework.

      KQ = key question.

    2. Figure.
      View larger version:
      Figure. Study flow diagram.

      KQ = key question. *Cochrane databases were the Cochrane Central Register of Controlled Trials, Cochrane Database of Systematic Reviews, and Database of Abstracts of Reviews of Effects. †Other sources were reference lists and expert referrals.

    3. Appendix Figure 2.
      View larger version:
      Appendix Figure 2. Diabetes incidence in lifestyle trials.

      DPP = Diabetes Prevention Program.

    4. Appendix Figure 3.
      View larger version:
      Appendix Figure 3. Diabetes incidence in drug trials.

      DPP = Diabetes Prevention Program; DREAM = Diabetes Reduction Assessment with Ramipril and Rosiglitazone Medication.

    Summary for Patients

    • Summaries for Patients:Screening for Type 2 Diabetes in Adults: U.S. Preventive Services Task Force Recommendations Ann Intern Med June 3, 2008 148:I-30
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med June 3, 2008 vol. 148 no. 11 855-868
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)
      1. Summary for Patients
    6. Recommendation Summary

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues